IKT logo

Inhibikase Therapeutics (IKT) Net Margin

Annual Net Margin

N/A

December 31, 2023


Summary


Performance

IKT Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIKTprofitabilitymetrics:

Quarterly Net Margin

N/A

September 30, 2024


Summary


Performance

IKT Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherIKTprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

IKT Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

IKT Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Inhibikase Therapeutics Net Margin History

DateAnnualQuarterly
Sep 2021
-
-1361.26%(+603.9%)
Jun 2021
-
-193.40%(+3.2%)
Mar 2021
-
-187.40%(-73.6%)
Dec 2020
-407.73%
-708.85%(-60.2%)
Sep 2020
-
-1779.72%(+826.4%)
Jun 2020
-
-192.12%(-5.0%)
DateAnnualQuarterly
Mar 2020
-
-202.17%(+13.0%)
Dec 2019
-509.73%(+856.9%)
-178.97%(-81.6%)
Sep 2019
-
-974.37%(-30.6%)
Jun 2019
-
-1404.30%(+378.1%)
Mar 2019
-
-293.75%
Dec 2018
-53.27%
-

FAQ

  • What is the all time high annual net margin for Inhibikase Therapeutics?
  • What is the all time high quarterly net margin for Inhibikase Therapeutics?

What is the all time high annual net margin for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high annual net profit margin is -53.27%

What is the all time high quarterly net margin for Inhibikase Therapeutics?

Inhibikase Therapeutics all-time high quarterly net profit margin is -178.97%